Skip to main content
Log in

Effect of One-Month Treatment with Nonsteroidal Antiinflammatory Drugs (NSAIDs) on Gastric pH of Rheumatoid Arthritis Patients

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The use of NSAIDs is strongly associated withpeptic ulceration. The inhibition of prostaglandinsynthesis with the consequent increase of gastricacidity is considered a possible mechanism. Therefore we decided to assess the effect of one-monthtreatment with NSAIDs on the circadian gastric pH ofrheumatoid arthritis (RA) patients. We studied 11consecutive patients (one man and 10 women, median age55, range 26-72 years) with confirmed RA. None wasH. pylori positive. A 24-hr gastric pH recording wasperformed both in basal conditions and after one-monthtreatment with either indomethacin 150 mg/day (eight cases) or ketoprofen 300 mg/day (three cases).Only the 10 female patients were eligible for finalanalysis, and six matched healthy subjects not takingNSAIDs were used as control group. The number of 24-hr pH readings for various pH thresholds wascalculated for both populations. The highest acid levels(pH < 3.0) did not differ between the two pH profilesof the control group (7440 vs 7391, P = NS), while they predominated after the one-month NSAIDtreatment (10,339 vs 11,440, P < 0.001) in RApatients. These findings show that there is an increasedgastric acidity after one-month of treatment with NSAIDs in female patients with RA of recent onset.This may sustain the rationale of using antisecretoryagents to prevent gastroduodenal ulcerations in thesepatients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Mahmud T, Scott DL, Bjarnason I: A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity. Ann Rheum Dis 55:211- 213, 1996

    PubMed  Google Scholar 

  2. Morini G, Grandi D, Arcari ML, Bertaccini G: Indomethacin-induced morphological changes in the rat gastric mucosa, with or without prior treatment with two proton pump inhibitors. Aliment Pharmacol Ther 9:615- 623, 1995

    PubMed  Google Scholar 

  3. Lichtenstein DR, Syngal S, Wolfe MM: Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Arthritis Rheum 38:5- 18, 1995

    PubMed  Google Scholar 

  4. Scheiman JM: Pathogene sis of gastroduodenal injury due to nonsteroidal antiinflammatory drugs: Implications for prevention and therapy. Semin Arthritis Rheum 21:201- 210, 1992

    Article  Google Scholar 

  5. Winship DH, Bernhard GC: Basal and histamine stimulated human gastric secretion: Lack of effect of indomethacin in therapeutic doses. Gastroenterology 58:762- 765, 1970

    Google Scholar 

  6. Bennett A, Stanford IF, Unger WG: Prostaglandin E2 and gastric acid secretion in man. J Physiol 229:349 - 360, 1973

    Google Scholar 

  7. Feldman M, Coltui TJ: Effect of indomethacin on gastric acid and bicarbonate secretion in humans. Gastroenterology 87:1339 - 1343, 1984

    Google Scholar 

  8. Rademaker JW, Rainsford KD, Stetsko PI, Johnson DM, Chiba N, Mcdonald TM, Hunt RH: The effect of indomethacin induced gastric mucosal injury on 24-h intragastric acidity and plasma gastrin concentration in healthy volunteers. Aliment Pharmacol Ther 9:625- 631, 1995

    Google Scholar 

  9. Janssen M, Baak LC, Jansen JBMJ, Dijkmans BAC, Vandenbrouke JP, Lamers CBHW: Effects of indomethacin on intragastric pH and meal-stimulated serum gastrin secretion in rheumatoid arthritis patients. Aliment Pharmacol The r 7:393- 400, 1993

    Google Scholar 

  10. Moss SF, Calam J: Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: The effect of eradication of Helicobacter pylori. Gut 34:888 - 898, 1993

    PubMed  Google Scholar 

  11. Arnett FC, Edworthy SM, Block DA: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315- 324, 1988

    PubMed  Google Scholar 

  12. El Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE: Helicobacter pyloriinfection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroente rology 109:681- 691, 1995

    Google Scholar 

  13. Patrono C, Patrignani P, Panara MR, Cipollone F, Santini G, Sciulli MG: COX-2 expression and inhibition in human monocytes. InImproved Non-Steroid Anti-Inflammatory Drugs. COX-2 Enzyme Inhibitors. J Vane, J Botting, R Botting (eds). Dordrecht, Kluwer Academic, 1996, pp 121- 131

    Google Scholar 

  14. Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L: Effect of omeprazole—a gastric proton pump inhibitor on pentagastrin stimulated acid secretion in man. Gut 24:270 - 276, 1983

    Google Scholar 

  15. Mela GS, Savarino V, Malesci A, Di Mario F, Sossai P, Vigneri S, Zambotti A: New method for improving accuracy of 24-hour continuous intragastric pH-metry. Reflections on physiological and pharmacological studies. Dig Dis Sci 39:1416 - 1424, 1994

    PubMed  Google Scholar 

  16. Mela GS, Savarino V, Moretti M, Bonifacino G, Sumberaz A, Zentilin P: Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases. Scand J Gastroenterol 24:683- 687, 1989

    PubMed  Google Scholar 

  17. Mela GS, Savarino V, Vigneri S: Optimizing the information obtained from continuous 24-hour pH monitoring. Am J Gastroenterol 87:961- 966, 1992

    Google Scholar 

  18. Harris ED Jr: Etiology and pathogenesis of rheumatoid arthritis. InTextbook of Rheumatology. VN Kelley, Ed Harris Jr, S Ruddy, H Sledge (eds). Philadelphia, WB Saunders, 1993, pp 833- 873

    Google Scholar 

  19. De Witte TJ, Geerdink PJ, Lamers CB, Boerbooms AM, Van der Korst JK: Hypochlorhydria and hypergastrinemia in rheumatoid arthritis. Ann Rheum Dis 38:14 - 17, 1979

    PubMed  Google Scholar 

  20. Baron JH: Lean body mass, gastric acid and peptic ulcer. Gut 10:637- 642, 1963

    Google Scholar 

  21. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA: Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 114:257- 263, 1991

    PubMed  Google Scholar 

  22. French PC, Darekar BS, Mills JG, Wood JR: Ranitidine in the prevention of non-steroidal anti-inflammatory drug-associated gastric and duodenal ulceration in arthritic patients. Eur J Gastroenterol Hepatol 6:1141- 1147, 1994

    Google Scholar 

  23. Taha AS, Hudson N, Hawkey CJ, Swannel AJ, Trye PN, Cottrel J, Mann SG, Simon TJ, Sturrock RD, Russell RI: Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med 334:1435- 1439, 1996

    PubMed  Google Scholar 

  24. Daneshmend TK, Stein AG, Bhaskar NK, Hawkey CJ: Abolition by omeprazole of aspirin-induced gastric mucosal injury in man. Gut 31:514 - 517, 1990

    PubMed  Google Scholar 

  25. Ekström P, Carling L, Wetterhus S, Wingren PE, Anker-Hansen O, Lundegärdh G, Thorhallsson E, Unge P: Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study. Scand J Gastroenterol 31:753- 758, 1996

    PubMed  Google Scholar 

  26. Cullen D, Bardhan KD, Eisner M, Kogut DG, Peacock RA, Thomson JM, Hawkey CJ: Primary gastroduodenal prophylaxis with omeprazole for NSAID users. Gastroenterology 110:A86, 1996

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Savarino, V., Sandro, G., Zentilin, M.P. et al. Effect of One-Month Treatment with Nonsteroidal Antiinflammatory Drugs (NSAIDs) on Gastric pH of Rheumatoid Arthritis Patients. Dig Dis Sci 43, 459–463 (1998). https://doi.org/10.1023/A:1018834301901

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018834301901

Navigation